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Objective: To determine the feasibility of using whole-
body cardiovascular MRI (WB-CVMR) to compare South
Asians (SAs)—a population known to have a higher risk of
cardiovascular disease (CVD) but paradoxically lower
prevalence of peripheral arterial disease—and Western
Europeans (WEs).
Methods: 19 SAs and 38 age-, gender- and body mass
index-matched WEs were recruited. All were aged
40 years and over, free from CVD and with a 10-year
risk of CVD ,20% as assessed by the adult treatment
panel (ATP) III risk score. WB-CVMR was performed,
comprising a whole-body angiogram (WBA) and cardiac
MR (CMR), on a 3-T MRI scanner (Magnetom® Trio;
Siemens, Erlangen, Germany) following dual-phase in-
jection of gadolinium-based contrast agent. A standard-
ized atheroma score (SAS) was calculated from the WBA
while indexed left ventricular mass and volumes were
calculated from the CMR.
Results: SAs exhibited a significantly lower iliofemoral
atheroma burden (regional SAS 0.060.0 vs 1.966.9,
p50.048) and a trend towards lower overall atheroma
burden (whole-body SAS 0.760.8 vs 1.862.3, p50.1).
They had significantly lower indexed left ventricular mass
(46.96 11.8 vs 56.96 13.4mlm22, p50.008), end diastolic
volume (63.96 10.4 vs 75.26 11.4mlm22, p50.001), end
systolic volume (20.566.1 vs 24.666.8mlm22, p50.03)
and stroke volume (43.466.6 vs 50.667.9mlm22,
p50.001), but with no significant difference in ejection
fraction, mass-volume ratio or global functioning index.
These differences persisted after accounting for CVD risk
factors.
Conclusion: WB-CVMR can quantify cardiac and ather-
oma burden and can detect differences in these metrics
between ethnic groups that, if validated, may suggest
that the paradoxical high risk of CVD compared with PVD
risk may be due to an adverse cardiac haemodynamic
status incurred by the smaller heart rather than
atherosclerosis.
Advances in knowledge: WB-CVMR can be used to
stratify and compare disease between ethnicities.
INTRODUCTION
Populations of South Asian (SA) origin and descent account
for 78% of all deaths and 86.3% of all loss of disability-
adjusted life years attributable to cardiovascular disease
(CVD), with elevated risk observed both in the population in
their native countries as well as in the global diaspora.1,2
Within Scotland, the SA population has a 16–53% higher risk
of both coronary artery disease, cardiac failure and stroke
incidence and mortality than the rest of the population.3–5
Despite this elevated risk for both coronary artery disease and
cerebrovascular disease, a paradoxical lower incidence of pe-
ripheral arterial disease (PAD) has been observed.6 Given that
coronary artery disease, stroke and PAD are all manifestations
of atherosclerosis, the cause for this disparity is uncertain.
Previous studies have examined carotid plaque burden and
coronary artery calciﬁcation differences between SAs and
Europeans; however, a major limitation of these studies is
that each of these examinations only gives information of
a single vascular territory thus missing contemporaneous
disease elsewhere within the body.7–10 Whole-body car-
diovascular MRI (WB-CVMR) is a technique which com-
prises cardiac MR (CMR) and whole-body MR angiography
(WB-MRA) sequences, allowing for the systemic assess-
ment of whole-body stenotic atheroma burden, with car-
diac structure, function and the detection of myocardial
scarring, in a single examination. CMR combined with late
gadolinium enhancement (LGE) is the gold standard for left
ventricular quantiﬁcation and detection of myocardial
scarring and provides important clinical and prognostic in-
formation both in disease and in the general population.11,12
Pericardial adipose tissue, which is independently associated with
the presence of coronary arterial disease, can also be quantiﬁed
from routine CMR sequences.13 The atheroma score from WB-
MRA has been shown to correlate well with traditional cardiac
risk factors, the prevalence of obstructive coronary artery disease
and future major adverse cardiovascular events.14–17 Thus, WB-
MRA holds the potential for systemic evaluation of stenotic
atheroma burden within an individual.
To date, neither CMR for the measurement of left ventricular
mass, function and epicardial fat nor WB-MRA for the mea-
surement of atheroma burden have been used to examine dif-
ferences in cardiac function and atheroma burden between ethnic
groups. We thus set out to determine the feasibility of using WB-
CVMR to detect and compare early changes in left ventricular
metrics and the atheroma burden in two separate ethnic groups.
METHODS AND MATERIALS
Ethics
The East of Scotland Research Ethics Committee approved the
protocols (07/S1402/42). The study was conducted at Ninewells
Hospital and Medical School, Dundee, UK, in accordance with
the Good Clinical Practice Declaration of Helsinki. The volun-
teers gave written informed consent to participate in this study.
Participants
Recruitment was from within the local community, running
from June 2008 until February 2011 via general practitioner in-
vitation or community-based recruitment. Recruitment criteria
for the main study were as follows: (i) aged more than 40 years
and (ii) free from known CVD or other indication for statin
therapy as recommended by the Scottish Intercollegiate Guide-
lines Network report 97 (www.sign.ac.uk) published in February
2007. Exclusion criteria included: (i) pregnancy; (ii) known
primary muscle disease; (iii) known atherosclerotic disease, in-
cluding unstable angina, previous myocardial infarction, PAD,
amputation, revascularization, hypertension, heart failure or ce-
rebrovascular event; (iv) known diabetes; (v) active liver disease;
(vi) other known illness or contraindication to MRI; (vii) par-
ticipation in a clinical trial; (viii) inability to give informed
consent; (ix) known alcohol abuse; and (x) blood pressure of
.145/95mmHg. SAs were deﬁned as participants of Indian,
Pakistani, Bangladeshi or Sri Lankan origin.
A total of 19 SAs were recruited, with 38 Western Europeans
(WEs) randomly selected from the 1515 volunteers from the
TAyside SCreening FOR Cardiovascular Events study, with these
selected to be age, sex, height, weight and body surface area
(BSA) matched to the SA cohort. Demographic data, anthro-
pomorphic measures and blood samples were collected at the
screening visit while the MRI scan was performed at the par-
ticipants second study visit.
MRI
Images were acquired as previously described.18 In brief, the
scans were performed on a 32 radio frequency (RF) receiver
channel, 3-T MRI scanner (Magnetom® Trio; Siemens,
Erlangen, Germany). For whole-body coverage, a combination
of six RF coils, including head matrix, neck matrix, spine matrix,
2 body matrices and peripheral angiography phased-array RF
surface coils, were used. The imaging protocol was carried out in
four phases: (i) CMR cine sequences of the left ventricle (LV),
(ii) MRA of the thoracic and neck, and distal lower limbs, (iii)
LGE obtained after a delay of 10min and (iv) MRA of the ab-
domen, pelvis and proximal lower limb.
Whole-body MR angiography protocol
WB-MRA images involved the acquisition of four overlapping three-
dimensional (3D) data sets using a coronal spoiled FLASH sequence
[repetition time (TR)52.6–3.47ms; echo time (TE)50.96–1.21
ms; ﬂip angle (FA)516–37°; pixel area51.1–1.5mm2 and slice
thickness51–1.4mm, slight variation according to station and
participant body habitus]. A dual injection, two-stage acquisition
with uptitring of gadoteric acid contrast agent (Dotarem®; Guerbet,
Villepinte, France) contrast volume was performed due to the ben-
eﬁts of this technique on image quality over a single injection
technique.19 Stations 1 and 4 were acquired after an injection of
10ml of gadoterate meglumine with a 20-ml saline ﬂush. Following
a delay of 15min, during which the LGE sequences were obtained,
Stations 2 and 3 were acquired following an injection of 15ml of
gadoterate meglumine with a 20-ml saline ﬂush. All injections of
contrast and saline were administered at 1.5ml s21.
Cardiac MR protocols
Left ventricular assessment involved the acquisition of a horizontal
long axis, vertical long axis and stacked short axis cine images with
repeated end-expiratory breath-holds, from the atrioventricular ring
to the apex. These were acquired using a cine TrueFISP sequence
with retrospective electrocardiographic gating (TR53.4ms;
TE51.48ms; FA550–60°; pixel area51.431.9mm2; slice
thickness56mm; interslice gap54mm). 10min after the in-
jection of the ﬁrst dose of contrast agent, the LGE images were
acquired using a two-dimensional phase-sensitive inversion re-
covery sequence (TR5846.4/5.21ms; TE51.99ms; FA520°;
pixel area51.431.9mm2; slice thickness56mm; inter-slice
gap54mm, phases525).
Whole-body MR angiography image analysis
The 3D WB-MRA data sets were viewed ofﬂine (Carestream
PACS Client Suite v. 10.1 sp1; Carestream Health, Rochester,
NY) as source images using both multiplanar reconstruction and
maximum intensity projections by one of four individuals ex-
perienced in WB-MRA reporting. Researchers were blind to the
participants’ ethnicity and clinical details during image analysis.
The arterial network was divided into 31 vessel segments
extending from the distal internal carotid arteries to the distal
points of the calf vessels.20 Segments were scored according to
the degree of narrowing of the lumen area, with stenosis graded
at the narrowest part of the vessel. When more than one stenosis
was present, the more severe (greater narrowing) of the two was
used to score the vessel. Categorical scores from 0 to 4 were
allocated to each vessel segment, where 05healthy segment with
no stenosis, 15,50% stenosis, 25 50–70% stenosis, 35 71–99%
stenosis and 45 vessel occlusion. The “standardized atheroma
score” (SAS) was calculated by summing each individual segment’s
stenosis score and divided by the number of diagnostic segments
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(n) before dividing by 4 which is the maximum potential score
[Equation (1)] as described previously:21
SAS5

+MRA score
n

4

3 100 (1)
The 31 vessel segments were subdivided into 5 anatomical ter-
ritories: (i) the head and neck arteries, (ii) the aorta, (iii) the
abdominal arteries, (iv) the iliofemoral arteries and (v) the run-
off arteries in the lower limbs. Regional standardized atheroma
scores were calculated for each anatomical territory.22
Cardiac MR image analysis
Left ventricular analysis images were analysed ofﬂine using
commercial software (Argus, Siemens Multi-modality Work
Platform v. VB15; Siemens) by 1 of 5 experienced researchers.
Segmentation involved tracing endocardial and epicardial
contours on the short-axis left ventricle images at end-
diastolic and end-systolic phases of the cardiac cycle. The
papillary muscles were treated as part of the blood pool vol-
ume unless they were indistinguishable from the myocardial
wall, and then they were assigned as left ventricle muscle.
Results were normalized to BSA using the DuBois formula.23
Left ventricular mass volume ratio (LVMVR) was calculated as
Left ventricular mass (LVM)/left ventricular end diastolic
volume (LVEDV). Left ventricular global function index
(LVGFI) was calculated as LVGFI5 [left ventricular stroke
volume (LVSV)/LV global volume]3 100.24 Late gadolinium
enhanced images of the left ventricle were inspected for evi-
dence of myocardial signal enhancement using Carestream
PACS Client Suite v. 10.1 sp1 (Carestream Health, Rochester,
NY). Epicardial adipose tissue (EAT) and paracardial adipose
tissue (PAT) were measured in the four-chamber balanced
steady state free precession sequence at end diastole using
Segment v. 1.9 R1917; (http://segment.heiburg.se).25 EAT was
deﬁned to be fat outwith the left ventricular myocardium and
deep to the visceral pericardium. PATwas deﬁned as the fat within
the mediastinum but outwith the parietal pericardium (Figure 1).
Thoracic adipose tissue was calculated by summing the EAT and
PAT areas. Results were normalized to BSA using the Dubois
formula. Reproducibility for both WB-MRA and CMR analyses
have been previously described in detail.18
Statistical methods
Data are expressed as mean6 standard deviation for contin-
uous variables, median (interquartile range) for ordinal vari-
ables and n (%) for nominal variables. The SAS was heavily
positively skewed and thus could not be transformed to
a normal distribution, therefore only non-parametric tests
were used for analysis of this variable. To test the null hy-
pothesis that samples originate from the same distribution, an
independent sample t-test was used for the parametric data,
and a Kruskal–Wallis test by ranks was used for the non-
parametric data. For categorical data, x2 or Fisher exact were
used as appropriate. Analysis of covariance was performed to
conﬁrm differences in cardiac volumes between the groups
with the normalized LVM, end diastolic volume (EDV), end
systolic volume (ESV) and LVSV each entered separately as the
dependant variable correcting for age, sex, body mass index
(BMI), blood pressure and smoking history. All data were
analysed using SPSS® statistical package v. 21.0 (IBM Corp.,
New York, NY; formerly SPSS Inc., Chicago, IL) and signiﬁ-
cance was assumed when p, 0.05.
RESULTS
19 SAs (58% males, 51.46 5.7 years) and 38 WEs (58% males,
50.86 5.6 years) completed the study protocol. The demographic
and CVD risk measures are documented in Table 1. Despite
having similar BMI and BSA, SAs had a larger waist size than
WEs (946 11 vs 886 10 cm, p5 0.04).
The SA group had lower LVM, EDV, ESV and stroke volume
(SV) (all p, 0.03; for full details, see Table 2). Despite these
changes, there was no signiﬁcant difference between the two
groups in LV functional parameters with similar ejection
fraction, LVMVR and LVGFI (all p. 0.6; for full details, see
Table 2). Neither group exhibited any evidence of myocardial
scarring on LGE imaging. On analysis of covariance, the
differences between the groups for LVM, EDV, ESV and SV all
persisted after accounting for age, sex, BMI, systolic and diastolic
blood pressure and smoking status (analysis of covariance results:
LVM p50.001; EDV p,0.001; ESV p50.028; SV p50.001).
WEs had a signiﬁcantly higher volume of PAT (7.466.2 vs 5.06
2.0 cm2m22, p50.04). There was no difference in EAT (2.761.7
vs 2.661.4 cm2m22, p50.8) or thoracic adipose tissue volume
(10.167.6 vs 7.662.8 cm2m22, p50.09) between the two groups.
On whole-body angiography, the majority of the vessels had no
evidence of disease, with 97% of vessels in the SA group and
95% of the vessels in WE group demonstrating no evidence of
stenotic atheroma formation (p. 0.05). The iliofemoral
segments showed a signiﬁcant difference between the two
groups with a higher local SAS in this region in the WE cohort
(1.96 6.9 vs 0.06 0.0, p5 0.048). Additionally, there was
a trend towards a lower global atheroma burden in the SA
population than the WE cohort (whole-body SAS 0.76 0.8 vs
Figure 1. Four-chamber balanced steady state free precession
image of the heart demonstrating the measurement of
epicardial adipose tissue (blue) and paracardial adipose tissue
(red) areas. SA, South Asian; WE, Western European. For
colour image see online.
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1.86 2.3, p5 0.10) (Figure 2). This effect was not site speciﬁc
with a similar pattern seen in all ﬁve of the anatomical vascular
territories (Table 3). These differences were caused by a higher
incidence of mild (1–49%) and moderate stenosis (50–70%) in
the WEs although neither of these reached signiﬁcance
(p5 0.10 and p5 0.08, respectively).
DISCUSSION
In this study, we have shown that WB-CVMR is a useful and
feasible technique for the comparison of cardiac function and
atheroma burden between different ethnic groups. Although this
was a preliminary study and the group sizes were small, this
technique was able to demonstrate for the ﬁrst time that healthy
SAs have a lower incidence of atherosclerosis in the iliofemoral
vessels and smaller hearts compared with WEs. These ﬁndings
demonstrate that even in those individuals with a low prevalence
of risk factors, early disease can be witnessed in a pattern that
might start to explain the paradoxically low incidence of PAD in
SAs compared with their markedly elevated risk of ischaemic
heart disease.
The ﬁnding of lower LV volumes and mass in SAs is consistent
with previous echocardiographic studies using both two-
dimensional and 3D echo, providing supportive evidence for
the validity of the ﬁndings of the technique.26,27 Despite sig-
niﬁcant differences in the left ventricular volumes and mass,
there were no differences in ejection fraction, mass : volume
ratio or left ventricular global function index. Both LVMVR and
LVGFI are measures of LV function that encompass both cavity
dimension and myocardial remodelling and are better prog-
nostic markers of incident cardiac events and stroke than LV
mass or volumes.11,24 Given that these values are preserved in
the SA cohort indicates that despite much smaller ventricular
dimensions, there is continued efﬁcient functionality of the left
ventricle. LV mass is known to correlate strongly with lean body
mass which is known to be lower in SAs than WEs, thus some of
the observed differences may be due to differences in body
composition.27,28 The observation that the SA cohort had
a larger waist size in our current study despite equivalent mass
and BMI would certainly suggest a higher percentage of fat mass
and thus lower lean body mass within the cohort which could
explain the discrepancy in mass between the two groups. Despite
lower lean body masses and, therefore in theory, lower LV mass
as a result of this, a previous study by Chahal et al29 demon-
strated the incidence of LVH and concentric LV remodelling,
both compensatory responses to LV wall stress, to be increased in
SAs compared with Europeans. Thus it may be hypothesized that
the smaller hearts which are having to produce the same cardiac
output as the larger WE hearts are put under adverse ventricular
wall stress. Indeed, diastolic function and ventricular relaxation
rates, markers of left ventricular ﬁbrosis and stiffening are also
impaired in SAs compared with WEs.27 However, further work in
this area is warranted to further evaluate and extricate the com-
parative effects of lean body mass, wall stress and ﬁbrosis.
Table 1. The population demographics of the participants
Parameter South Asian Western European p-value
n 19 38
Male (%) 11 (58%) 22 (58%) 1
Age (years) 51.46 5.7 50.86 5.6 0.7
Heart rate 64.26 8.0 60.16 7.6 0.1
Systolic BP 1206 14 1236 11 0.5
Diastolic BP 736 10 736 10 0.9
Total cholesterol 5.16 1.1 5.46 1.2 0.3
LDL cholesterol (mmol l21) 3.16 0.8 3.46 0.9 0.3
HDL cholesterol (mmol l21) 1.16 0.4 1.36 0.3 0.08
Triglycerides (mmol l21) 1.86 0.9 1.86 1.0 0.9
Fasting glucose 5.26 1.0 5.16 1.0 0.6
ATP III risk score 3.86 3.5 3.66 3.2 0.9
BMI (kgm22) 27.86 3.0 27.36 2.9 0.5
BSA (m2) 1.96 0.2 1.96 0.2 0.2
Waist (cm) 946 11 886 10 0.04
Current/exsmoker (%) 3 (16%) 6 (16%) 1
SIMD 8 (7–8) 8 (5–9) 0.3
Family history of CVD 8 (26%) 16 (26%) 1
ATP, adult treatment panel; BMI, body mass index; BP, blood pressure; BSA, body surface area; CVD, cardiovascular disease; HDL, high-density
lipoprotein; LDL, low-density lipoprotein; SIMD, Scottish Index of Multiple Deprivation.
Values expressed as mean6 standard deviation, median (inter quartile range) or n (%).
Bold values indicate p,0.05.
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However, evidence supporting either of these potential causative
mechanisms is limited but is an interesting avenue for future work.
In our current study, we have demonstrated for the ﬁrst time
a signiﬁcantly greater burden of stenotic arterial disease within
the pelvic vessels of WEs compared with SAs and a trend to-
wards greater global atheroma burden. These ﬁndings will
require validation in a larger cohort and provide the pre-
liminary work required to justify such a study. Despite the
small group numbers involved, there are several reasons that
Figure 2. Scatter plot comparing whole-body standardized atheroma score (SAS) between the South Asian (SA) and Western
European (WE) cohorts.
Table 2. Comparison of cardiac MRI metrics between the two groups
Parameter South Asian Western European p-value
LVM (gm22) 46.96 11.8 56.96 13.4 0.008
LVEDV (mlm22) 63.96 10.4 75.26 11.4 0.001
LVESV (mlm22) 20.56 6.1 24.66 6.8 0.028
LVSV (mlm22) 43.46 6.6 50.66 7.9 0.001
LVEF (%) 68.36 5.9 67.56 6.6 0.68
CI (lmin21m2) 5.066 7.9 6.146 9.8 0.6
LVMVR (gml21) 0.796 0.14 0.786 0.16 0.9
LVGFI 49.26 7.9 48.56 6.5 0.7
LGE (%) 0 (0) 0 (0) 1
EAT (cm2m22) 2.66 1.4 2.76 1.7 0.8
PAT (cm2m22) 5.06 2.0 7.46 6.2 0.04
TAT (cm2m22) 7.66 2.8 10.16 7.6 0.09
EAT/TAT 0.346 0.1 0.296 0.09 0.12
CI, cardiac index; EAT, epicardial adipose tissue; LVEDV, indexed left ventricular end diastolic volume; LVEF, left ventricular ejection fraction; LVESV,
indexed left ventricular end systolic volume; LVM, left ventricular mass; LVMVR, left ventricular mass volume ratio; LVGFI, left ventricular global
function index; LVSV, indexed left ventricular stroke volume; LGE, late gadolinium enhancement; PAT, paracardial adipose tissue; TAT, thoracic
adipose tissue.
Values expressed as mean6 standard deviation or n (%).
Bold values indicate p,0.05.
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increase the likelihood of these results representing the true
differential burden of disease between populations. Prior
studies, which have used ankle brachial pressure index as
a surrogate marker for the presence of peripheral vascular
disease, have demonstrated a reduced prevalence of PAD in
SAs, and a poor concordance of ankle brachial pressure index
with the presence of coronary artery disease status within the
SA populace, both of which would support the observation of
a lower atherosclerotic burden within the lower limb
vasculature.30,31 Although previous studies have demonstrated
similar carotid intima media thickness (CIMT) and plaque
volume in SAs and Europeans,7,8 the discordance between
similar CIMT in SAs and Europeans and our current ﬁndings
of higher peripheral vascular disease in WEs can at least be
partly explained by the relatively poor concordance of CIMT
with global atheroma burden.32,33
Despite similar height, weight, BMI and BSA, the SA group had
a larger waist size which is a known risk factor for future di-
abetes and cardiovascular events.34 A previous study has dem-
onstrated a positive correlation between visceral adiposity and
atheroma score using whole-body angiography, and thus the
ﬁndings observed in the SA group are contrary to expectations.35
In addition, despite this elevation in waist size, commensurate
increase in the EAT volume was not observed, in fact the op-
posite was observed within the paracardial fat, with the WE
population exhibiting a greater volume of paracardial fat. Epi-
cardial fat has been described to be a risk factor for coronary
artery disease due to its perivascular release of chemokines and
cytokines,13 thus the lack of differences between the populations
removes this as a potential source of the regional variation in
plaque formation. Paracardial fat has also been described as a risk
factor for the development of diabetes and CVD,36 thus the ob-
served higher volumes within the WE population than the SA
population is contrary to expectations and again points away from
this as a possible contributory factor to explain the higher incidence
of diabetes and cardiovascular events in the SA populace.
The strengths of the current study are its novelty and its si-
multaneous assessment of the cardiac and vascular network in
a single examination. There are, however, several limitations.
The sample size is small and the study is single centred, lim-
iting the generalizability of the results, thus replication in
a larger multicentre cohort is required with the current study
providing an important ﬁrst step in the justiﬁcation for such
work. WB-MRA is a lumenographic technique, thus extraluminal
plaque formation will be missed, potentially underestimating
atheroma burden in the populations. However, whilst techniques
such as black blood imaging may hold the potential for analysis of
early wall thickening and stenosis assessment, this technique has
yet to be used and validated in whole-body vascular assessment,
unlike the current angiographic technique. The voxel size of the
lower limb angiography station is such that assessment of the
more distal smaller calibre arteries was challenging and could thus
underestimate infrageniculate disease as is seen in the diabetic
population.37 Information on exercise was not available within the
current study thus confounding effects of differential exercise
patterns (which are known to affect LV metrics) between the two
cohorts cannot be excluded. Finally, the differences between the
cardiac mass and volumes are calculated after indexing to the
BSA. Observed differences could therefore be secondary to in-
appropriate allometric normalization from BSA calculations
which were derived in a white population, especially given the
larger waist size in the SA cohort. However, given that the height,
weight and BMI are matched between the cohorts and that similar
results were observed using the raw LV data, the effect of this is
likely to be negligible, especially given the magnitude of the dif-
ferences between the groups.
CONCLUSION
WB-CVMR can quantify cardiac and atheroma burden and can
detect differences in these metrics between ethnic groups that, if
validated, suggests that the paradoxical high risk of CVD compared
with PVD risk may be due to an adverse cardiac haemodynamic
status incurred by the smaller heart rather than atherosclerosis.
Table 3. Comparison of MR angiography metrics between the two groups
Parameter South Asian Western European p-value
WB SAS 0.76 0.8 1.86 2.3 0.10
Head/neck SAS 0.56 1.1 1.96 4.0 0.21
Aorta SAS 0.96 2.6 1.36 3.1 0.59
Abdomen SAS 1.86 3.8 3.26 4.4 0.26
Iliofemoral SAS 0.06 0.0 1.96 6.9 0.048
Run-off SAS 0.76 2.2 0.96 2.9 0.77
Normal vessels 501 (97%) 1117 (95%) 0.2
Vessels with 1–50% stenosis 14 (3%) 46 (4%) 0.1
Vessels with 51–70% stenosis 1 (0.2%) 9 (0.8%) 0.08
Vessels with 71–99% stenosis 0 3 (0.2%) 0.3
Occluded vessels 0 1 (0.01%) 0.3
SAS, standardized atheroma score; WB, whole-body.
Values expressed as mean6 standard deviation, median (inter quartile range) or n (%).
Bold value indicates p,0.05.
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